These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32215658)

  • 21. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colchicine: an old wine in a new bottle?
    Roubille F; Kritikou E; Busseuil D; Barrere-Lemaire S; Tardif JC
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):14-23. PubMed ID: 23286287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Disease in Spondyloarthritides.
    Papagoras C; Voulgari PV; Drosos AA
    Curr Vasc Pharmacol; 2020; 18(5):473-487. PubMed ID: 31330576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
    Hemkens LG; Ewald H; Gloy VL; Arpagaus A; Olu KK; Nidorf M; Glinz D; Nordmann AJ; Briel M
    Heart; 2016 Apr; 102(8):590-6. PubMed ID: 26830663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine as an anti-inflammatory and cardioprotective agent.
    Gasparyan AY; Ayvazyan L; Yessirkepov M; Kitas GD
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1781-94. PubMed ID: 26239119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Inflammation to Reduce Residual Cardiovascular Risk.
    Ajala ON; Everett BM
    Curr Atheroscler Rep; 2020 Sep; 22(11):66. PubMed ID: 32880743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fuel for thought: immunometabolism is a paradigm shift in understanding immunity in cardiovascular disease.
    Caligiuri G; Norata GD
    Cardiovasc Res; 2019 Jul; 115(9):1383-1384. PubMed ID: 31199480
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular Disease.
    Teunissen AJP; van Leent MMT; Prévot G; Brechbühl EES; Pérez-Medina C; Duivenvoorden R; Fayad ZA; Mulder WJM
    Arterioscler Thromb Vasc Biol; 2021 Jun; 41(6):1839-1850. PubMed ID: 33882685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summaries for patients. Colchicine treatment for recurrent pericarditis.
    Ann Intern Med; 2011 Oct; 155(7):I28. PubMed ID: 21873706
    [No Abstract]   [Full Text] [Related]  

  • 33. Repurposing Metformin for Cardiovascular Disease.
    Rena G; Lang CC
    Circulation; 2018 Jan; 137(5):422-424. PubMed ID: 29378754
    [No Abstract]   [Full Text] [Related]  

  • 34. Colchicine for Secondary Cardiovascular Prevention: A Systematic Review.
    Webb CA; Barry AR
    Pharmacotherapy; 2020 Jun; 40(6):575-583. PubMed ID: 32259308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
    Yong J; Tian J; Jiang W; Zhao X; Zhang H; Song X
    Clin Ther; 2022 Aug; 44(8):1150-1159. PubMed ID: 35907660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.
    Golpour M; Mousavi T; Alimohammadi M; Mosayebian A; Shiran M; Alizadeh Navaei R; Rafiei A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211031763. PubMed ID: 34250834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials.
    Andreis A; Imazio M; Avondo S; Casula M; Paneva E; Piroli F; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):637-644. PubMed ID: 33399344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
    Li Z; Lin C; Cai X; Hu S; Lv F; Yang W; Zhu X; Ji L
    Atherosclerosis; 2023 Aug; 379():117181. PubMed ID: 37527612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy: Colchicine for recurrent pericarditis--what's new in CORP-2?
    Syed FF; Mayosi BM
    Nat Rev Cardiol; 2014 Jul; 11(7):376-8. PubMed ID: 24866425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.